Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Armando Tejeda-Mansir"'
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 33, Iss 1, Pp 195-203 (2019)
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglected tropical disease with severe clinical manifestations. The development of feasible bioprocesses to obtain such vaccines is a public-health priority
Externí odkaz:
https://doaj.org/article/1bccd92193914371989bc75e954985e7
Autor:
JOSE RODRIGUEZ, Ana Sophia Altamirano-Carranza, Armando Tejeda-Mansir, Juan Antonio Noriega-Rodríguez, Carmen Lizette Del Toro Sánchez
Publikováno v:
Biotecnia. 24:157-163
Kefir is a fermented milk with proven bioactivities and popularity worldwide. However, kefir grains biomass (KGB) limits its production. The effect of different substrates on the KGB increase and antioxidant activity (AC) was investigated. Kefir grai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d4bcd737654287e1437b286d984089c
https://doi.org/10.18633/biotecnia.v24i1.1614
https://doi.org/10.18633/biotecnia.v24i1.1614
Autor:
Adolfo Sánchez-Romero, Anselmo Miranda-Baeza, José Antonio López-Elías, Luis Rafael Martínez-Córdova, Armando Tejeda-Mansir, Enrique Márquez-Ríos
Publikováno v:
Latin American Journal of Aquatic Research, Vol 41, Iss 5, Pp 888-897 (2013)
Se evaluó el efecto del fotoperiodo y la relación de biomasa camarón:macroalga en la remoción de nitrógeno amoniacal total (NAT), por la macroalga Gracilaria vermiculophylla, en cultivo con camarón Litopenaeus vannamei, sin recambio de agua. Se
Externí odkaz:
https://doaj.org/article/e567f7361fdd4353a7d96cca15830383
Autor:
Adriana Padilla-Zamudio, J. Armando Lucero-Acuña, Patricia Guerrero-Germán, Jaime Ortega-López, Armando Tejeda-Mansir
Publikováno v:
Applied Sciences, Vol 8, Iss 1, p 30 (2017)
The release kinetics of pDNA in a bead mill was studied. Samples taken during the process were analyzed to determine total pDNA (pDNA(t)) and supercoiled pDNA (pDNA(sc)) concentration. In order to identify important variables of the process and to de
Externí odkaz:
https://doaj.org/article/74bc188281604ba0b3ebb58ee73690dd
Autor:
Cindy Alejandra Gutiérrez-Valenzuela, Patricia Guerrero-Germán, Armando Tejeda-Mansir, Reynaldo Esquivel, Roberto Guzmán-Z, Armando Lucero-Acuña
Publikováno v:
Applied Sciences, Vol 6, Iss 12, p 364 (2016)
Plasmid DNA (pVAX1-NH36) was encapsulated in nanoparticles of poly-dl-lactic-co-glycolic (PLGA) functionalized with polyethylene glycol (PEG) and folic acid (PLGA-PEG-FA) without losing integrity. PLGA-PEG-FA nanoparticles loaded with pVAX1-NH36 (pDN
Externí odkaz:
https://doaj.org/article/bdf380ff858b4b6e90e745e9d3a436e1
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 33, Iss 1, Pp 195-203 (2019)
The use of plasmid DNA (pDNA) for human vaccines is a novel approach against leishmaniasis, a neglected tropical disease with severe clinical manifestations. The development of feasible bioprocesses to obtain such vaccines is a public-health priority
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223d58eb0c4b911696d714940e67060a
https://doi.org/10.1080/13102818.2018.1560232
https://doi.org/10.1080/13102818.2018.1560232
Publikováno v:
Fuel. 235:1077-1082
Leishmaniasis is an endemic disease mainly in very poor countries. This disease may cause only a cutaneous lesion but also a fatal visceral disease. Vaccines of plasmid DNA (pDNA) are an alternative of conventional treatments of the disease since are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40032fef44179810b72af03324e3d662
https://doi.org/10.1016/j.fuel.2018.08.070
https://doi.org/10.1016/j.fuel.2018.08.070
Autor:
Isis, Pérez-Concepción1 a221230212@unison.mx, Armando, Tejeda-Mansir1
Publikováno v:
Mexican Journal of Biotechnology. Jan-Mar2023, Vol. 8 Issue 1, p145-145. 1p.
Autor:
Roberto Guzman, Armando Tejeda-Mansir, Rodolfo Munguía-Soto, Rosa Ma. Montesinos-Cisneros, Aurora García-Rendón
Publikováno v:
Journal of Chemical Technology & Biotechnology. 92:342-349
BACKGROUND The clinical application of plasmid DNA (pDNA) vaccines is progressing and it is essential to develop industrial bioprocesses to economically manufacture these macromolecules. In order to contribute to achieving this goal, in this work an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b221a8d89f0fcc9a37676da5b1befa
https://doi.org/10.1002/jctb.5011
https://doi.org/10.1002/jctb.5011
Publikováno v:
Biotechnologygenetic engineering reviews. 35(1)
Vaccination is the most effective and least expensive technique used for human diseases prevention and eradication. The need for more vaccine doses and the rapid establishment of facilities for the development of new vaccines are stimulating signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba3fa3eea402850a6d02846bd2d1089
https://pubmed.ncbi.nlm.nih.gov/30587085
https://pubmed.ncbi.nlm.nih.gov/30587085